Sequence analysis of the V3 loop in brain and spleen of patients with HIV encephalitis

AIDS Research and Human Retroviruses

Volumn 12, Issue 6, 1996, Pages 477-482

  Reddy, Raghavendar T ^a   Achim, Cristian L ^a   Alexa Sirko, D ^a   Tehranchi, Samira ^a   Gunter Kraus, F ^a   Wong Staal, Flossie ^a   Wiley, Clayton A ^a,b  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ANALYTIC METHOD; ARTICLE; BRAIN TISSUE; ENCEPHALITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE RESPONSE; MOLECULAR CLONING; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SPLEEN; VIRUS REPLICATION; VIRUS VIRULENCE;

EID: 0029917265     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.477     Document Type: Article

References (40)

1. Anonymous: Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type-1 (HIV-1) infection. Neurology 1991;41:778-785.
2. Navia BA, Jordan BD, and Price RW: The AIDS dementia complex. I. Clinical features. Ann Neurol 1986;19:517-524.
3. Glass JD, Wesselingh SL, Seines OA, and McArthur JC: Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 1993;43:2230-2237.
4. Vazeux R, Lacroix-Ciaudo C, Blanche S, Cumont MC, Henin D, Gray F, Boccon-Gibod L, and Tardieu M: Low levels of human immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndrome encephalopathy. Am J Pathol 1992;140:137-144.
5. Navia BA, Cho ES, Petito CK, and Price RW: The AIDS dementia complex. II. Neuropathology. Ann Neurol 1986;19:525-535.
6. Wiley CA and Achim C: Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol 1994;36:673-676.
7. Wiley C, Schrier RD, Nelson JA, Lampert PW, and Oldstone MB: Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 1986;83:7089-7093.
8. Gartner S, Markovits P, Markovitz DM, Betts RF, and Popovic M: Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. JAMA 1986;256:2365-2371.
9. Gabuzda DH, Ho DD, de la Mos, Hirsch M, Rota TR, and Sobel RA: Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol 1986;20:289-295.
10. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour G, Yungbluth M, Janotta F, Aksamit A, Martin MA, and Fauci AS: Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986;233:1089-1093.
11. Stoler MH, Eskin TA, Benn S, Angerer RC, and Angerer LM: Human T-cell lymphotropic virus type III infection of the central nervous system. A preliminary in situ analysis. JAMA 1986;256: 2360-2364.
12. Desrosiers RC, Hansen-Moosa A, Mori K, Bouvier DP, King NW, Daniel MD, and Ringler DJ: Macrophage-tropic variants of SIV are associated with specific AIDS-related lesions but are not essential for the development of AIDS. Am J Pathol 1991;139:29-35.
13. Heyes MP, Brew B, Martin A, Price RW, Salazar AM, Sidtis J, Yergey JA, Mouradian MM, Sadler AE, Keilp J, et al.: Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: Relationship to clinical and neurological status. Ann Neurol 1991;29:202-209.
14. Giulian D, Wendt E, Vaca K, and Noonan CA: The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc Natl Acad Sci USA 1993;90:2769-2773.
15. Dreyer EB, Kaiser PK, Offermann JT, and Lipton SA: HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 1990;248:364-367. [See comments]
16. Achim CL, Wang R, Miners DK, and Wiley CA: Brain viral burden in HIV-infection. Neuropathol Exp Neurol 1994;53:284-294.
17. Johnson RT: Viral Infections of the Nervous System. Raven Press, New York, 1982.
18. Ho DD, Rota TR, Schooley R, Kaplan JC, Allan JD, Groopman JE, Resnick L, Felsenstein D, Andrews CA, and Hirsch M: Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985;313:1493-1497.
19. Shaunak S, Albright RE, Klotman ME, Henry SC, Bartlett JA, and Hamilton JD: Amplification of HIV-1 provirus from cerebrospinal fluid and its correlation with neurologic disease. J Infect Dis 1990;161:1068-1072.
20. Chiodi F, Valentin A, Keys B, Schwartz S, Asjo B, Gartner S, Popovic M, Albert J, Sundqvist VA, and Fenyö EM: Biological characterization of paired human immunodeficiency virus type 1 isolates from blood and cerebrospinal fluid. Virology 1989; 173:178-187.
21. Koyanagi Y, Miles S, Mitsuyasu RT, Merrill JE, Vinters HV, and Chen IS: Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 1987;236:819-822.
22. McNearney T, Hornickova Z, Markham R, Birdwell A, Arens M, Saah A, and Ratner L: Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. Proc Natl Acad Sci USA 1992;89:10247-10251.
23. Epstein LG, Kuiken C, Blumberg BM, Hartman S, Sharer LR, Clement M, and Goudsmit J: HIV-1 V3 domain variation in brain and spleen of children with AIDS: Tissue-specific evolution within host-determined quasispecies. Virology 1991;180:583-590.
24. Li YX, Kappes JC, Conway JA, Price RW, Shaw GM, and Hahn BH: Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: Identification of replication-competent and -defective viral genomes. J Virol 1991;65:3973-3985.
25. Pang S, Vinters HV, Akashi T, O'Brien WA, and Chen IS: HIV-1 env sequence variation in brain tissue of patients with AIDS-related neurologic disease. J Acquir Immune Defic Syndr 1991;4:1082-1092.
26. Power C, Mcarthur JC, Johnson RT, Griffin DE, Glass JD, Perryman S, and Chesebro B: Demented and nondemented patients with AIDS differ in brain-derived human-immunodeficiency-virus type-1 envelope sequences. J Virol 1994;68:4643-4649.
27. Ball JK, Holmes EC, Whitwell H, and Desselberger U: Genomic variation of human immunodeficiency virus type 1 (HIV-1): Molecular analyses of HIV-1 in sequential blood samples and various organs obtained at autopsy. J Gen Virol 1994;75:67-79.
28. Monken CE, Wu B, and Srinivasan A: High resolution analysis of HIV-1 quasispecies in the brain. AIDS 1995;9:345-349.
29. Korber BT, Kunstman KJ, Patterson BK, Furtado M, McEvilly MM, Levy R, and Wolinsky SM: Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: Evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 1994;68:7467-7481.
30. Donaldson YK, Bell JE, Holmes EC, Hughes ES, Brown HK, and Simmonds P: In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop. J Virol 1994;68:5991-6005.
31. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, and Wiley CA: Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992;32:321-329.
32. Heaton RK, Velin RA, Mccutchan JA, Gulevich SJ, Atkinson JH, Wallace MR, Godfrey H, Kirson DA, Grant I, Oldfield EC, Chandler JL, Malone J, Spector SA, Thal L, Hesselink J, Jernigan T, Wiley CA, Olshen R, Abramson I, Butters N, Dupont R, Patterson T, Zisook S, Jeste D, Sieburg H, and Weinrich JD: Neuropsychological impairment in human-immunodeficiency-virus infection - implications for employment. Psychosom Med 1994;56:8-17.
33. Kure K, Weidenheim KM, Lyman WD, and Dickson DW: Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration. Acta Neuropathol (Berl) 1990;80:393-400.
34. Achim CL, Heyes MP, and Wiley CA: Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J Clin Invest 1993;91:2769-2775.
35. Keys B, Karis J, Fadeel B, Valentin A, Norkrans G, Hagberg L, and Chiodi F: V3 sequences of paired HIV-1 isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stage of disease. Virology 1993;196: 475-483.
36. Ivanoff LA, Dubay JW, Morris JF, Roberts SJ, Gutshall L, Sternberg EJ, Hunter E, Matthews TJ, and Petteway SJ: V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity. Virology 1992;187:423-432.
37. Collin M, Illei P, James W, and Gordon S: Definition of the range and distribution of human-immunodeficiency-virus macrophage tropism using PCR-based infectivity measurements. J Gen Virol 1994;75:1597-1603.
38. Westervelt P, Gendelman HE, and Ratner L: Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes. Proc Natl Acad Sci USA 1991;88:3097-3101.
39. Cheng MC, Quiroga M, Tung JW, Dina D, and Levy JA: Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation. J Virol 1990;64:4390-4398.
40. Chesebro B, Wehrly K, Nishio J, and Ferryman S: Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: Definition of critical amino acids involved in cell tropism. J Virol 1992;66:6547-6554.